Form 8-K · Current report
Welltower 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0000766704
- Accession no.
- 0001628280-26-067627
Summary
Welltower filed a Form 8-K with the SEC covering three prospectus supplements that register the possible issuance of up to 166,666 shares under the Welltower Fellowship Grant honoring Charles T. Munger, up to 334,938 shares issuable on exchange of Class B LP Units of HCN Canadian Investment (Silver Quebec) LP, and up to 1,146,886 shares issuable on redemption of Class A units of Welltower OP LLC. The filing includes legal and tax opinions from Gibson, Dunn & Crutcher LLP.
Key points
- The Fellowship Grant shares may be issued only if eligibility, service and performance conditions are satisfied.
- Registration of the LP Shares and OP Shares does not mean holders will exercise their exchange or redemption rights.
- The three supplements were filed under a base prospectus dated March 28, 2025, part of an automatic shelf registration on Form S-3.
- Gibson, Dunn & Crutcher LLP supplied the opinions and consents attached as exhibits.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. Fellowship Grant Prospectus Supplement On October 27, 2026, Welltower Inc., a Delaware corporation (the “Company”), filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement (the “Fellowship Grant Prospectus Supplement”) to the base prospectus dated March 28, 2025 (the “Base Prospectus”) included in the Company’s automatic shelf registration statement on Form S-3 (File No. 333-286204) (the “Registration Statement”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.